Promisia Healthcare HY26 Interim Results

Market Announcement
12 November 2025
PROMISIA HEALTHCARE HY26 INTERIM RESULTS
Execution and performance focus delivers operational and financial gains
• Underlying EBITDAF up 31% to $2.5 million with operating revenue rising 47% to $19.2
million in HY26
• Group care occupancy improved from 87% to 90% since March 2025; Aldwins House
reaching record occupancy above 90%
• New Chief Operating Officer delivers rapid results through comprehensive facility health
checks, operational improvements and unified systems implementation
• Balance sheet strengthened through disciplined capital allocation with non-core Aldwins
properties sold and free cash flo w applied to Golden View ownership advancement
• Pro-forma LVR improving to approximately 40.7%
• Positioned for sustainable growth with early-stage acquisition negotiations underway
supported by improving earnings and reduced leverage

Promisia Healthcare Limited (Promisia) (NZX: PHL) has announced its unaudited results for the six
months ended 30 September 2025 (HY26).
The first half of FY26 marks a significant milestone for Promisia. After a year laying new foundations,
the company is now demonstrating disciplined execution and meaningful operational momentum
across every part of its business.
Chair Rhonda Sherriff said: “In May 2025, we welcomed Graeme Dodd as Chief Operating Officer – a
strategic appointment that has already proven transformative. He is working collaboratively
alongside Francisco Rodriguez Ferrere as Chief Financial Officer and together they have focused on
performance, accountability and cash generation.”
The results speak for themselves: group care occupancy has climbed from approximately 87% at
March to around 90% now, with individual facilities showing even stronger momentum. That is
reflected favourably in Promisia’s financial performance, together with a continuing focus on
liquidity and balance sheet discipline.

Financial performance
Promisia’s first-half underlying EBITDAF increased 31% to $2.5 million from $1.9 million a year
earlier, supported by a 47% rise in operating revenue to $19.2 million in the same period.
The company already upgraded its full-year underlying EBITDAF guidance to at least $6.1 million,
representing growth exceeding 45% year-on-year, up from its initial guidance of 25% growth.
“This substantial upgrade reflects the successful execution of the five strategic levers we outlined at
our AGM, all of which are now delivering ahead of schedule,” Rhonda Sherriff said.

Promisia reported a profit before income tax of $240,000 for the half year compared with $5.45
million a year earlier. However, these figures are heavily influenced by non-cash accounting items
that do not reflect underlying operating performance. The prior result included a $5.18 million non-
cash bargain-purchase gain from the Cromwell acquisition, while the current period includes
$736,000 of non-cash imputed interest on the associated vendor loan.

Operational transformation
The arrival of the new COO has driven tangible improvements across the portfolio. Comprehensive
facility health checks were conducted across every community, identifying both strengths to
celebrate and clear opportunities for improvement, providing a roadmap tailored to each site.
At Aldwins House, the transformation has been particularly impressive. Occupancy has lifted from
85% at March to over 90% – the highest in the facility’s history. This was achieved through clarifying
our market position, improving standards and ensuring appropriate resident placement to meet
their care needs.
At Ranfurly, there has been exceptional momentum in care suite sales – climbing from
approximately 50% sold at March to over 80% now.
Facility managers are flourishing under the new leadership and feeling genuinely empowered and
inspired to achieve above and beyond results.
Operational improvements include consolidating suppliers to leverage group scale; implementing
unified quality management systems providing real-time clinical information across all sites; and
introducing new time and attendance systems. By early November, every site will operate on the
same resident management platform – critical infrastructure for consistency and future growth.

Financial discipline and balance sheet strength
Financial discipline has remained central to the strategy throughout the half-year. Also, the
Cromwell operations now deliver a full-year earnings contribution with clear efficiency gains.
“We continued disciplined capital allocation in the half-year and applied free cashflow to advance
Golden View ownership at $180,000 monthly,” Rhonda Sherriff said.
Targeted value-add projects like the Nelson Street conversion and Ranfurly care suite refurbishment
were completed, while non-core properties at Aldwins were sold to reduce debt and strengthen
liquidity.
The company’s loan-to-value ratio continues to improve, providing balance sheet flexibility for
future investment opportunities. On a pro forma basis after the Aldwins Road property sales are
considered, LVR will be approximately 40.7%.

Looking Ahead
With operational systems on the path to becoming embedded and earnings momentum established,
the second half will focus on targeted growth and development opportunities for existing facilities.
“Promisia is in early negotiations for a potential acquisition that aligns with our model of large-scale
integrated care and village facilities in regional locations. We are also assessing developments of
existing facilities that can be funded sustainably within our balance sheet capacity,” Rhonda Sherriff
said.
The combination of improving earnings, reduced leverage and stronger cash flow positions Promisia
well for the next stage of growth in a measured and sustainable way.

Authority for this announcement:
Francisco Rodriguez Ferrere – Chief Financial Officer, Promisia Healthcare Limited

For more information, please contact: Francisco Rodriguez Ferrere
Phone: +64 21 245 1801 or email: Francisco.rf@promisia.co.nz

About Promisia Healthcare
Promisia is a New Zealand based aged care and retirement living provider, with a focus on delivering
quality personalised care. Our aim is to be the aged care provider of choice in our communities. Our
facilities are located in well-established and well serviced towns and metropolitan areas. Our goal is
to profitably grow our business in a sustainable manner, delivering quality care to our residents,
peace of mind to their families and whanau, and excellent value to our villages, community and
shareholders. Promisia is listed on the NZX (NZX: PHL). http://www.promisia.co.nz.

---

FOR THE SIX MONTHS ENDED
30 SEPTEMBER 2025
INTERIM
REPORT

Contents
Chair’s Report 3
Key Financials and Operations 4
Operations Report 5
Occupancy 6
Financial Review 7
Unaudited Consolidated Interim Financial Statements 9
Condensed Consolidated Statement of Comprehensive Income 10
Condensed Consolidated Statement of Financial Position 11
Condensed Consolidated Statement of Changes in Equity 13
Condensed Consolidated Statement of Cash Flows 15
Notes to Financial Statements 16
Directory 30
Cover photo: Bowling at Golden View Lifestyle Village.
Aldwins House.
PROMISIA HEALTHCARE: INTERIM REPORT 2026 2

The first half of FY26 marks a significant
milestone for Promisia. After a year
laying new foundations, we are now
demonstrating disciplined execution
and meaningful operational momentum
across every part of our business.
In May 2025, we welcomed Graeme Dodd as Chief
Operating Officer – a strategic appointment that
has already proven transformative. Graeme brings
deep sector expertise as both a seasoned operator
and registered nurse, combining business acumen
with an in-depth understanding of clinical care
delivery.
He is working alongside Francisco Rodriguez
Ferrere as Chief Financial Officer and together
they have focused on performance, accountability
and cash generation. This senior leadership team
represents the required calibre and capability
needed to drive sustainable growth.
The results speak for themselves: group care
occupancy has climbed from approximately 87% at
March to around 90% now, with individual facilities
showing even stronger momentum. We have
upgraded our FY26 underlying EBITDAF guidance
to at least $6.1 million – representing growth
exceeding 45% year-on-year. These outcomes
reflect sustainable operational improvement, not
one-off adjustments.
The measurable impact of new operations
leadership
Graeme’s impact has been immediate and
meaningful. Upon joining, he conducted
Chair’s Report
comprehensive
facility health
checks across every
community. This
rigorous process
identified both
strengths to celebrate
and clear opportunities for improvement, providing
a roadmap tailored to each site.
At Aldwins House, the transformation has been
particularly impressive. Occupancy has lifted
from 85% at March to over 90% – the highest in
the facility’s history. This was achieved through
clarifying our market position, improving standards
and ensuring appropriate resident placement to
meet their care needs. The facility now has clear
messaging: quality east-side Christchurch care
with ensuite rooms in every bedroom, and standard
care fees only. This simple, honest positioning
has resonated strongly with families and referral
agencies alike.
At Ranfurly, there has been exceptional momentum
in care suite sales – climbing from approximately
50% sold at March to over 80% now.
Our facility managers are flourishing under
Graeme’s leadership and feeling genuinely
empowered and inspired to achieve above and
beyond results.
Behind the scenes, he has driven crucial operational
improvements: consolidating suppliers across
incontinence products, wound care and food
services to leverage group scale; implementing
unified quality management systems providing
real-time clinical information across all sites; and
Chair Rhonda Sherriff
Aldwins House.
PROMISIA HEALTHCARE: INTERIM REPORT 2026 3

introducing new time and attendance systems.
By early November, every site will operate on the
same resident management platform – critical
infrastructure for consistency and future growth.
Financial discipline and balance sheet strength
O
ur financial performance reflects this operational
momentum. The five strategic levers we outlined
at the AGM are all delivering in line with our
strategic plan.
Nelson Street’s dementia conversion is steadily
building occupancy. Ranfurly Manor’s care suite
sales translate directly into stronger cash flows.
Cromwell operations are fully embedded with
material efficiency gains. Aldwins occupancy has
reached record levels. And, overall, the July 2025
uplift in aged-care funding was welcomed to help
the facilities offset ongoing cost pressures.
We continued disciplined capital allocation in the
half-year and applied free cash flow to advance
Golden View ownership. Targeted value-add
projects like the Nelson Street conversion and
Ranfurly care suite refurbishment were completed.
Non-core neighbouring properties at Aldwins were
sold to reduce debt and strengthen liquidity. Our
loan-to-value ratio continues to improve, providing
balance sheet flexibility for future investment
opportunities.
Looking Ahead
With operational systems on the path to becoming
embedded and earnings momentum established,
the second half will focus on targeted growth
and development opportunities. We are in early
negotiations for a potential acquisition that aligns
with our model of large-scale integrated care and
village facilities. We are also assessing developments
of existing facilities that can be funded sustainably
within our balance sheet capacity.
I want to sincerely thank our people across
every facility and the support office. Through
significant change, they have continued delivering
professional, empathetic care with genuine
heart. The Board has absolute confidence in our
leadership team and their ability to execute the
strategy we are committed to.
Key Financials and Operations
Underlying EBITDAF
31%
LVR (pro-forma basis)
4 0.7%
Guidance upgrade for full-year underlying EBITDAF
45%
Cashflow from
operating activities
87%
Group occupancy
90%
at least
PROMISIA HEALTHCARE: INTERIM REPORT 2026 4

Operations Report
Building a foundation for growth
We’ve aligned our operations at all five group sites
with the intention that every bed is a promise: a
promise to keep residents safe, care for them and
support them to live the very best life possible. We
have set very high and consistent standards of care
and quality that must be met.
Since May 2025, each facility has undergone a
comprehensive health check – a critical first step in
establishing the operational foundation necessary
for sustainable growth.
This thorough assessment examined every aspect
of our operations: leadership capability, equipment
and infrastructure, staffing ratios and rosters,
cleanliness standards, resident mix and feedback
and marketing positioning. The process revealed
both strengths to recognise and opportunities to
realise, providing a clear blueprint for improvement
at each site.
The health check has driven meaningful change.
For example, at Aldwins House, we clarified our
market position – offering east Christchurch rest
home and hospital care with ensuite in every room,
and standard care fees only. We also addressed
resident mix challenges that had long affected the
facility’s culture and reputation, making difficult
but necessary decisions to ensure all residents are
appropriately placed for their care needs.
Our refreshed Aldwins marketing message
resonated immediately with families and referral
agencies, contributing to occupancy climbing from
85% to over 90%, the highest level in the facility’s
history. This occupancy turnaround is one of the
most visible examples of our new operational
leadership, underlining what disciplined culture
change and consistent, high-quality care delivery
can achieve in a
relatively short period
of time. Of course,
that feeds directly
into our bottom line.
The commitment to
clinical excellence remains
paramount. Ranfurly recently had a very
successful audit and very likely to receive another
four-year certification – the highest standard
available and a clear external validation of care
quality. Our newer acquisitions are undergoing
system integration to achieve similar standards,
with the long-term goal of four-year certification
across every facility in our group.
We’ve adopted a culture of continuous
improvement and are growing, learning and
developing together as a team. We’re enhancing our
tools, systems, applications and processes so our
successes are repeatable and scalable and we are
as efficient as possible.
Operationally, we’ve consolidated key suppliers
across incontinence products, wound care and food
services, leveraging our group scale for improved
efficiency. We’re also embracing technology to
remove barriers and free staff to focus on care.
Aldwins now pilots artificial intelligence phone
assistance, efficiently capturing enquiry details
and enabling immediate manager follow-up while
offering online tour booking.
A unified quality management system providing
real-time clinical information has been
implemented across all facilities and a new
time and attendance system was introduced.
From November, every site will operate on the
same resident management platform – critical
infrastructure for consistency and growth.
Looking ahead to the second half of FY26, our
priorities are clear: continue lifting and holding
occupancy across all sites, with every facility
targeting at least 95%; refine our operational recipe
to ensure consistent outcomes; expand technology
adoption to enhance efficiency; and maintain our
relentless focus on clinical compliance and care
quality. These fundamentals create an environment
which fosters growth.
With our systems now embedded and quick wins
being realised, we are well-positioned to scale
our business model and actively pursue strategic
growth opportunities.
Nelson Street.
Chief Operating Officer
Graeme Dodd
PROMISIA HEALTHCARE: INTERIM REPORT 2026 5

Aldwins House
90%
Care Beds
5
Care Suites /
Apartments
Ranfurly Manor
1
Ripponburn Home
and Hospital
3
94%
Villas
Golden View
Lifestyle Village
2
81%100%
98%100%100%
93%100%
Nelson Street
4
63%
1
A further two care suites are under application or
contract, which would lift occupancy to 84% once
settled.
2
100 of the villas at Golden View Lifestyle Village are
occupied, with the remaining two under contract,
settling in October. 18 of the apartments are
occupied, with the remaining one under contract
and to be settled/occupied in early November.
3
At Ripponburn Home & Hospital, 14 of the 16
villas are occupied, with the remaining two under
contract and expected to settle in the near term.
4
Occupancy at Nelson Street has continued to
build steadily since completion of the dementia
conversion in June 2025. The facility reached
66% at September month-end, with momentum
continuing thereafter.
5
Monthly average occupancy for September.
Occupancy
Total Group
90%86%100%
PROMISIA HEALTHCARE: INTERIM REPORT 2026 6

Financial Review
Strong earnings growth
The first half of FY26 demonstrates that our
strategic reset is delivering material financial
results. Operational execution improvements have
boosted occupancy and ultimately that is reflected
favourably in our financial performance. We are
continuing to focus on liquidity and balance sheet
discipline.
Our first-half underlying EBITDAF increased 31%
to $2.5 million from $1.9 million a year earlier,
supported by a 47% rise in operating revenue to
$19.2 million in the same period.
We have upgraded our full-year underlying
EBITDAF guidance to at least $6.1 million,
representing growth exceeding 45% year-on-year,
up from our initial guidance of 25% growth.
This substantial upgrade reflects the successful
execution of the five operational levers we outlined
at our AGM, all of which are now delivering ahead
of schedule.
We reported a profit before income tax of $240,000
for the half year compared with $5.45 million a
year earlier. The
prior result included
a $5.18 million
non-cash bargain-
purchase gain
from the Cromwell
acquisition, while
the current period
includes $736,000 of non-cash imputed interest
on the associated vendor loan. These technical
non-cash items affect net profit but do not reflect
operating performance.
Five growth drivers in action
The Cromwell operations now deliver their full-year
earnings contribution with clear efficiency gains.
The centralised kitchen at Golden View, servicing
both sites, exemplifies how we’re reducing costs by
reducing duplication, while maintaining quality.
At Aldwins House, occupancy reached a historic
high of 90% in September, a remarkable turnaround
from 70% in 2023. This improvement, achieved
through leadership stability and consistent local
Chief Financial Officer
Francisco Rodriguez Ferrere
Aldwins House.
PROMISIA HEALTHCARE: INTERIM REPORT 2026 7

engagement, is among our portfolio’s strongest
success stories.
Our Nelson Street dementia conversion, completed
in June 2025, is building occupancy steadily with
the facility reaching 66% at September month-end.
This positions Nelson Street as a key dementia care
provider in the central North Island region, while
improving our overall care mix and revenue per bed.
Ranfurly Manor care suite sales have accelerated
dramatically from approximately 50% sold at March
to 81% at September, with a further two suites
under contract. These sales translate directly into
enhanced cash flows through both Occupation
Right Agreements resales and ongoing care fees.
The July 2025 aged care funding rate increase of
4% supported the company to offset ongoing cost
pressures.
Our balance sheet continues strengthening through
disciplined capital allocation. Free cash flow has
been applied to advance Golden View ownership at
$180,000 per month, and together with repayments
of core bank debt, $1.7 million of cash was used
to repay borrowings during the period. Non-core
property sales at Aldwins House, settling mid-
November, will further reduce debt and improve
liquidity. Our loan-to-value ratio has improved from
42.9% at March to 41.9% at September. On a pro
forma basis after the Aldwins Road property sales
are considered, LVR will be approximately 40.7%.
NTA and value creation
Net Tangible Assets (NTA) per share has remained
broadly flat at the half year due to our annual
valuation cycle. However, given the material
improvements in occupancy, strong sales
momentum and operational performance, we
expect a meaningful uplift when properties are
revalued at full year. Our track record – lifting NTA
per share from $0.46 (March 2023) to $0.79 (March
2025) – demonstrates consistent value creation
and this year’s operational gains position us to
continue that trajectory at year end.
The financial fundamentals are strong, momentum
is clear and we’re well positioned for continued
growth in the second half. A specific acquisition
opportunity has been identified and early
negotiations have begun. Alongside that, we are
assessing development of existing sites.
The combination of improving earnings, reduced
leverage and stronger cash flow positions Promisia
well for the next stage of expansion in a measured
and sustainable way.
EBITDA Reconciliation
HY26HY25
EBITDA2,4027,020
Bargain purchase on
business acquisitions
-5,181
EBITDAF
1
2,4021,839
Discretionary Executive
Director payment
9560
Non-recurring management
share incentives
4850
Underlying EBITDAF
2
2,5451,949
1
EBITDAF is operating earnings before interest, tax,
depreciation, amortisation and fair value adjustments and is
a non-GAAP number.
2
Underlying EBITDAF is EBITDAF excluding transactions
considered to be non-trading in nature or size. Excluding
these transactions from normalised earnings can assist users
in forming a view of the underlying performance of the Group.
Ranfurly Manor.
PROMISIA HEALTHCARE: INTERIM REPORT 2026 8

Promisia Healthcare Limited
UNAUDITED CONSOLIDATED
INTERIM FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
PROMISIA HEALTHCARE: INTERIM REPORT 2026 9

PROMISIA HEALTHCARE LIMITED
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
Note
30 September
2025
UNAUDITED
30 September
2024
UNAUDITED
$ '000$ '000
Revenue
Care and village fees18,23012,352
Deferred management fees (DMF)933596
Gain on signing new occupation right agreements2098
19,18313,046
Other income
Bargain purchase on business acquisitions-5,181
-5,181
Total revenue and other income19,18318,227
Less: expenses
Operating expenses(14,728)(9,727)
Administration expenses(2,053)(1,466)
Depreciation expense(277)(156)
Finance costs
- Borrowing costs(1,149)(1,431)
- Vendor loan imputed interest expense(736)-
(18,943)(12,780)
Profit before income tax expense2405,447
Income tax expense(289)(97)
Net (loss) / profit from continuing operations(49)5,350
Net profit from discontinued operations-435
(Loss) / profit for the period(49)5,785
Other comprehensive income--
Total comprehensive (loss) / income
(49)5,785
(Loss) / earnings per share (cents per share)
Basic (loss) / earnings per share from continuing operations 8 (0.1855) 23.4810
Diluted (loss) / earnings per share from continuing operations 8 (0.1855) 22.4137
Basic earnings per share from discontinued operations 8 - 1.9092
Diluted earnings per share from discontinued operations 8 - 1.8224
The accompanying notes form part of these condensed consolidated financial statements.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 3 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 10

PROMISIA HEALTHCARE LIMITED
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
AS AT 30 SEPTEMBER 2025
Note
30 September
2025
UNAUDITED
30 September
2024
UNAUDITED
31 March
2025
AUDITED
$ '000$ '000$ '000
Assets
Cash and cash equivalents12761132
Trade receivables and other assets2,5542,5731,805
Current tax assets-8-
Non-current assets held for sale1,60110,0461,601
Right-of-use assets12132--
Property, plant and equipment223,76822,26223,763
Investment properties3145,710158,392144,785
Total assets173,892193,342172,086
Liabilities
Payables5,4474,6034,273
Current tax liabilities419-376
Liabilities directly associated with assets
classified as held for sale10-8,352-
Revenue received in advance4,6462,7284,056
Occupation right agreements475,51987,00475,058
Borrowings543,45146,81042,222
Convertible notes62,8216,0004,465
Related party payables9-175-
Lease liabilities12134--
Deferred tax liabilities2,2002,4332,364
Total liabilities134,637158,105132,814
Net assets
39,25535,23739,272
The accompanying notes form part of these condensed consolidated financial statements.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 4 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 11

PROMISIA HEALTHCARE LIMITED
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
AS AT 30 SEPTEMBER 2025
Note
30 September
2025
UNAUDITED
30 September
2024
UNAUDITED
31 March
2025
AUDITED
$ '000$ '000$ '000
Equity
Share capital782,08882,03982,056
Reserves4,4983,0664,498
Accumulated losses(48,226)(49,868)(48,817)
Convertible notes reserve895-1,535
Total equity
39,25535,23739,272
Net tangible asset backing per share (dollars) 0.79 0.72 0.79
Signed
on behalf of the Board of Directors, dated
Director:
Rhonda Sherriff
Director:
Thomas Brankin
The accompanying notes form part of these condensed consolidated financial statements.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 5 -
Wednesday 12 November 2025
PROMISIA HEALTHCARE: INTERIM REPORT 2026 12

PROMISIA HEALTHCARE LIMITED
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
Note
Contributed
equityReserves
Accumulated
losses
Convertible
notes reserveTotal equity
$ '000$ '000$ '000$ '000$ '000
Consolidated
Balance as at 1
April 2024
77,4673,066(55,653)-24,880
Profit for the
period--5,785-5,785
Other
comprehensive
income for the
period-----
Total
comprehensive
income for the
period--5,785-5,785
Transactions with
owners in their
capacity as
owners:
Contributions4,572---4,572
Total transactions
with owners in
their capacity as
owners4,572---4,572
Balance as at 30
September 2024
(UNAUDITED)
82,0393,066(49,868)-35,237
The accompanying notes form part of these condensed consolidated financial statements.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 6 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 13

PROMISIA HEALTHCARE LIMITED
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
Note
Contributed
equityReserves
Accumulated
losses
Convertible
notes reserveTotal equity
$ '000$ '000$ '000$ '000$ '000
Balance as at 1
April 2025
82,0564,498(48,817)1,53539,272
Loss for the period--(49)-(49)
Other
comprehensive
income for the
period-----
Total
comprehensive
income for the
period--(49)-(49)
Transactions with
owners in their
capacity as
owners:
Contributions732---32
Convertible notes
lapsed6--640(640)-
Total transactions
with owners in
their capacity as
owners32-640(640)32
Balance as at 30
September 2025
(UNAUDITED)
82,0884,498(48,226)89539,255
The accompanying notes form part of these condensed consolidated financial statements.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 7 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 14

PROMISIA HEALTHCARE LIMITED
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
Note
30 September
2025
UNAUDITED
30 September
2024
UNAUDITED
$ '000$ '000
Cash flow from operating activities
Receipts from residents for care fees and services18,21914,559
Receipts of residents' loans from new sales4,6601,186
Payments to suppliers and employees(16,134)(12,851)
Repayments of residents' loans(2,704)(161)
Interest paid(1,132)(1,318)
Income tax (paid) / received(100)67
Net cash provided by operating activities2,8091,482
Cash flow from investing activities
Payment for property, plant and equipment(261)(193)
Payment for investment property(795)(978)
Payment for acquisition of subsidiaries, net of cash acquired-(13,778)
Net cash used in investing activities(1,056)(14,949)
Cash flow from financing activities
Net proceeds from share issue7-4,572
(Repayment of) / net proceeds from borrowings(1,729)8,838
Principal portion of lease payments(28)-
Net cash (used in) / provided by financing activities(1,757)13,410
Reconciliation of cash
Cash at beginning of the financial period131118
Net decrease in cash held(4)(57)
Cash at end of financial period
12761
The accompanying notes form part of these condensed consolidated financial statements.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 8 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 15

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
NOTE 1: STATEMENT OF MATERIAL ACCOUNTING POLICIES
The condensed consolidated financial statements presented are those of Promisia Healthcare Limited (the
Company), and its subsidiaries (the Group). Promisia Healthcare Limited is a profit-oriented entity
incorporated in New Zealand. Promisia Healthcare Limited’s principal activities are the ownership and
operation of retirement villages, rest homes, and hospitals for the elderly within New Zealand.
Promisia Healthcare Limited is a Financial Markets Conduct Act reporting entity under the Financial
Reporting Act 2013 and the Financial Markets Conduct Act 2013.
These condensed consolidated financial statements have been approved for issue by the Board of Directors
on Wednesday 12 November 2025.
(a) Basis of preparation of the condensed financial report
The condensed consolidated financial statements comprise the following: condensed consolidated
statement of comprehensive income, condensed consolidated statement of financial position, condensed
consolidated statement of changes in equity, condensed consolidated statement of cash flows, and
condensed accounting policies and notes to the condensed consolidated financial statements.
These condensed consolidated financial statements have been prepared in accordance with NZ IAS 34
Interim Financial Reporting, and should be read in conjunction with the Group's last consolidated financial
statements as at and for the year ended 31 March 2025 (‘last annual financial statements’). These do not
include all of the information required for a complete set of NZ IFRS financial statements. However,
selected explanatory notes are included to explain events and transactions that are significant to an
understanding of changes in the Group's financial position and performance since the last consolidated
financial statements.
The Group's accounting policies have been applied consistently to all periods presented in these condensed
financial statements.
The information is presented in New Zealand dollars, the Group’s functional and presentation currency, and
rounded to the nearest thousand dollars unless stated otherwise.
There is no seasonality or cyclicality of the operations.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 9 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 16

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
NOTE 1: STATEMENT OF MATERIAL ACCOUNTING POLICIES (CONTINUED)
(b) Going concern
The consolidated financial statements have been prepared on a going concern basis, which contemplates
continuity of normal business activities and the realisation of assets and the settlement of liabilities in the
ordinary course of business.
The Directors are comfortable that based on the historic performance, detailed cash flow projections, and
the support provided by shareholders, the Group will be able to meet its cash flow requirements as they fall
due.
It is the continuing opinion of the Board of Directors that there are reasonable grounds to believe that its
operational and financial plans in place are achievable, and accordingly the Group is able to continue as a
going concern and meet its debts as and when they fall due. Accordingly, use of the going concern
assumption remains appropriate in these circumstances.
(c) Comparatives
Where necessary, comparative information has been reclassified and repositioned for consistency with
current
six months disclosures.
(d) Segment reporting
The Group operates a number of rest homes and retirement villages. These facilities all provide a similar
product to a similar customer in the same regulatory environment.
The Group operates in one operating segment being the provision of aged care in New Zealand. The chief
operating decision maker, the Board of Directors, reviews the operating results on a regular basis and
makes decisions on resource allocation based on the review of Group results and cash flows as a whole.
Therefore, it is appropriate to report solely on the Group performance.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 10 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 17

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
Note
30 September
2025
UNAUDITED
30 September
2024
UNAUDITED
31 March
2025
AUDITED
$ '000$ '000$ '000
NOTE 2: PROPERTY, PLANT AND EQUIPMENT
Land and buildings
At fair value23,02021,20922,885
Accumulated depreciation(1,135)(1,135)(1,135)
21,88520,07421,750
Plant and equipment
At cost3,1863,1883,266
Accumulated depreciation(1,303)(1,000)(1,253)
1,8832,1882,013
Total property, plant and equipment
23,76822,26223,763
(a) Reconciliations
Reconciliation of the carrying amounts of property, plant
and equipment at the beginning and end of the current
financial period
Land and buildings at fair value
Opening carrying amount21,75020,05020,050
Additions1352426
Net amount of revaluation increments less
decrements--1,674
Closing carrying amount
21,88520,07421,750
Plant and equipment at cost
Opening carrying amount2,0131,2691,269
Additions126169259
Disposals(49)-(85)
Acquisitions through business combinations*-979979
Depreciation expense(207)(156)(409)
Reclassified as held for sale or held in disposal-(73)-
Closing carrying amount
1,8832,1882,013
* On 28 August 2024, the Group acquired plant and equipment as part of the Golden View Lifestyle Village
and Golden View Care and Ripponburn Home and Hospital business combination, refer to note 28 of the
Group’s audited consolidated financial statements for the year ended 31 March 2025.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 11 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 18

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
NOTE 3: INVESTMENT PROPERTIES
During the period, investment properties have increased from $144.785m at 31 March 2025 to $145.710m
at 30 September 2025 being an increase of $0.925m (2025: Increased from $61.012m at 31 March 2024 to
$158.392m at 30 September 2024 being an increase of $97.380m*). The movement primarily relates to the
recognition of costs for the remaining four premium care suites at Ranfurly Manor. These suites were
developed under a fixed-price related party development agreement with Colspec Construction Limited and
have now all been sold under ORA arrangements, completing the development programme.
* On 28 August 2024, the Group acquired investment properties as part of the Golden View Lifestyle Village
and Golden View Care and Ripponburn Home and Hospital business combination, refer to note 28 of the
Group’s audited consolidated financial statements for the year ended 31 March 2025.
Note
30 September
2025
UNAUDITED
30 September
2024
UNAUDITED
31 March
2025
AUDITED
$ '000$ '000$ '000
NOTE 4: OCCUPATION RIGHT AGREEMENTS
Opening 75,05822,01222,012
Received on issue of new ORAs4,6602,3008,370
Repaid on termination of ORAs(2,704)(1,114)(4,414)
Deferred management fees (per contract) (1,499)(788)(3,106)
Acquired upon business combinations-67,41354,529
Transferred out due to discontinued operation-(2,819)(3,000)
Increase due to fair value uplift of investment
properties--667
Other4--
75,51987,00475,058
NOTE 5: BORROWINGS
Current
Unsecured liabilities
Other loans2,0722,4001,595
Secured liabilities
Bank loans20,9418,2331,017
23,01310,6332,612
Non-current
Secured liabilities
Bank loans10,50021,32131,070
Other loans9,93814,8568,540
20,43836,17739,610
43,45146,81042,222
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 12 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 19

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
NOTE 5: BORROWINGS (CONTINUED)
BNZ Loans
Term loans are secured by first mortgage security over the aged care facilities. BNZ loans consist of the
following facilities:
Maturity dateInterest rateFacility
($'000)
Drawn
($'000)
Undrawn
($'000)
As at 30 September 2025
30 October 20252.29%5151-
9 March 20266.32%700320380
14 August 20266.83%7,5007,500-
14 August 20266.01%1,1701,170-
20 August 20267.59%11,90011,900-
30 March 20276.00%7,5007,500-
14 January 20286.80% 3,000
3,000 -
31,821 31,441 380
Maturity date
Interest rateFacility
($'000)
Drawn
($'000)
Undrawn
($'000)
As at 30 September 2024
31 March 20258.62%7,5007,500-
30 October 20252.29%784784-
9 March 20268.57%700700-
14 August 20268.28%1,1701,170-
14 August 20267.13%7,5007,500-
20 August 20267.59% 11,900
11,900 -
29,554 29,554 -
Maturity dateInterest rateFacility
($'000)
Drawn
($'000)
Undrawn
($'000)
As at 31 March 2025
30 October 20252.29%417417-
9 March 20267.06%700600100
14 August 20266.91%7,5007,500-
14 August 20266.66%1,1701,170-
20 August 20267.59%11,90011,900-
30 March 20276.66%7,5007,500-
14 January 20286.80% 3,000
3,000 -
32,187 32,087 100
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 13 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 20

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
NOTE 5: BORROWINGS (CONTINUED)
As of 30 September 2025, the Group classified its secured Bank of New Zealand facilities of $10.500m (30
September 2024: $21.321m, 31 March 2025: $31.070m) as non-current liabilities. This borrowing is subject
to financial covenants under the Group’s financing arrangements with Bank of New Zealand, which are
tested and reported quarterly. The covenants require the Group to maintain a Loan to Value Ratio and a
minimum amount of EBITDA (earnings before interest, tax expense, depreciation and amortisation of
intangibles) less vendor loan payments. The Group complied with all covenant requirements during the
reporting period and as of 30 September 2025. Based on management’s forecast and assessment,
continued compliance is expected for at least the next 12 months, and there is no material risk that the
non-current borrowings will become repayable within that period.
There is an all obligations unlimited interlocking company guarantee between the following entities in the
Group: Promisia Healthcare Limited, Aged Care Holdings Limited, Ranfurly Manor Limited, Nelson Street
Resthome Limited, Aldwins House Limited, Aldwins Retirement Village Limited, Golden View Care Limited
and Thyme Care Limited.
Other Loans consist of:
Insurance premium funding
The Group entered into a short-term funding arrangement with Hunter Premium Funding for the payment
of insurance premiums.
The carrying amount of liabilities under supplier finance arrangement is $0.711m (30 September 2024:
$0.366m, 31 March 2025: $0.135m), of which the supplier has received $0.711m (30 September 2024:
$0.366m, 31 March 2025: $0.135m) from the finance provider.
All liabilities under this arrangement are current.
Vendor loan
As part of the Golden View Lifestyle Village acquisition, the Group entered into a vendor loan agreement
with Rivercrest Cromwell Limited with a nominal value of $13.350m.
The loan is interest-free and repayable in August 2028. It is structured as follows:
A non-refundable deposit of $8.64m, payable in 48 equal monthly instalments of $180,000,
commencing August 2024.
A final payment of $4.710m due in August 2028.
Initial recognition
The vendor loan was initially recognised at fair value at acquisition date to determine the purchase
consideration. The fair value was determined using a discounted cash flow model under NZ IFRS 13,
reflecting the time value of money.
Subsequent measurement
Following acquisition, the loan is measured at amortised cost. The difference between its fair value and
nominal amount is recognised as imputed interest expense over the loan term. No further fair value
adjustments are made post-acquisition.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 14 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 21

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
NOTE 5: BORROWINGS (CONTINUED)
Carrying value reconciliation:
30 September
2025
UNAUDITED
Carrying Value
($'000)
30 September
2024
UNAUDITED
Carrying Value
($'000)
31 March
2025
AUDITED
Carrying Value
($'000)
Vendor loan - current portion
1,3612,0341,460
Vendor loan - non-current portion9,93810,9568,540
Total
11,29912,99010,000
During the period, a nominal amount of $2.500m from Tranche 1 of the convertible note lapsed and was
reclassified to vendor loan, which is due on 28 August 2028, refer to Note 6.
NOTE 6: CONVERTIBLE NOTES
30 September 2025
UNAUDITED
30 September 2024
UNAUDITED
31 March 2025
AUDITED
Number
on issue
Nominal
Value
Number
on issue
Nominal
Value
Number
on issue
Nominal
Value
(000's)$'000(000's)$'000(000's)$'000
Opening balance6,0006,000----
Tranche 1--2,5002,5002,5002,500
Tranche 2--3,5003,5003,5003,500
Tranche 1 lapsed
and transferred to
vendor loan(2,500)(2,500)----
Closing balance
3,5003,5006,0006,0006,0006,000
As part of the Golden View acquisition, the Group issued 6.0m unquoted convertible notes to Rivercrest
Cromwell Limited, the vendor of the Golden View Lifestyle Village. The convertible notes were issued as
part of the deferred consideration under the Sale and Purchase Agreement.
Key Terms of the Convertible Notes
The notes are interest-free and mature on 28 August 2028.
The notes may be converted into ordinary shares at the discretion of the noteholder prior to maturity.
The initial conversion price was $0.001 per share, adjusted to $0.50 per share following the 500:1 share
consolidation.
Any notes not converted will be redeemed at face value in cash at maturity.
Shares issued upon conversion will rank equally with all other ordinary shares in Promisia Healthcare
Limited.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 15 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 22

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
NOTE 6: CONVERTIBLE NOTES (CONTINUED)
Key Terms of the Convertible Notes (Continued)
TermsExercise periodMaturity Date
Tranche 1Any time before the one-year anniversary date of
the Grant Date
28 August 2025
Tranche 2Any time before the four-year anniversary of the
Grant Date
28 August 2028
During the period, Tranche 1 of the convertible notes, with a nominal value of $2.5 million, was not
exercised and was reclassified to the vendor loan, which is due on 28 August 2028.
Recognition and Measurement
The convertible notes are compound financial instruments, as they can be converted by the holder at any
time until maturity to a fixed number of ordinary shares.
The liability component of compound financial instruments is initially recognised at the fair value of a
similar liability that does not have an equity conversion option. The equity component is initially recognised
at the difference between the fair value of the compound financial instrument as a whole and the fair value
of the liability component. Any directly attributable transaction costs are allocated to the liability and
equity components in proportion to their initial carrying amounts.
Subsequent to initial recognition, the liability component of a compound financial instrument is measured
at amortised cost under the effective interest method. The equity component of a compound financial
instrument is not remeasured.
Carrying value reconciliation:
30 September 2025
UNAUDITED
30 September 2024
UNAUDITED
31 March 2025
AUDITED
Nominal
Value
($'000)
Carrying
Value
($'000)
Nominal
Value
($'000)
Carrying
Value
($'000)
Nominal
Value
($'000)
Carrying
Value
($'000)
Convertible notes
(liability)
3,5002,8216,0006,0006,0004,465
Value of
conversion rights
on convertible
notes (equity)
-895---1,535
Total3,5003,7166,0006,0006,0006,000
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 16 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 23

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
NOTE 7: SHARE CAPITAL
30 September 2025
UNAUDITED
30 September 2024
UNAUDITED
31 March 2025
AUDITED
Number
(000's)$ '000
Number
(000's)$ '000
Number
(000's)$ '000
Opening balance52,60482,05621,475,64277,46721,475,64277,467
Capital raise--4,796,1664,7964,725,0004,725
Transaction costs
relating to capital raise---(224)-(225)
Share based payments8932--71,22789
Total shares issued
and paid89324,796,1664,5724,796,2274,589
Share consolidation of
500:1--(26,219,264)-(26,219,265)-
At reporting date
52,69382,08852,54482,03952,60482,056
The Group's share capital includes fully paid shares.
Share based payments
On 11 April 2025, 89,333 ordinary shares were issued upon the conversion of Restricted Share Units (RSUs)
in Promisia Healthcare Limited granted under the 2023 Senior Executive Restricted Share Plan Rules. The
shares were satisfied through non-cash consideration for services rendered by a senior executive and
recognised as employee benefit expense in profit or loss, at a value of $0.3592 per share (being the 20-
business-day Volume Weighted Average Price (VWAP) of Promisia Healthcare Limited’s ordinary shares
prior to the vesting date of the RSUs), totalling $0.032m.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 17 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 24

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
30 September
2025
UNAUDITED
30 September
2024
UNAUDITED
$ '000$ '000
NOTE 8: EARNINGS PER SHARE
Profit attributable to ordinary shareholders (basic & dilutive)
(Loss) / profit from continuing operations(49)5,350
Profit from discontinued operations-435
Total (loss) /profit attributable to ordinary shareholders(49)5,785
CentsCents
per share per share
Cents per share
Basic earnings per share
Basic (loss) / earnings per share from continuing operations(0.1855)23.4810
Basic earnings per share from discontinued operations-1.9092
Diluted earnings per share
Diluted (loss) / earnings per share from continuing operations(0.1855)22.4137
Diluted earnings per share from discontinued operations-1.8224
Number of Number of
shares shares
000's000's
Weighted average number of shares for basic EPS26,41622,784
Effect of conversion of convertible notes-1,085
Weighted average number of shares (diluted)26,41623,869
The calculation of basic earnings per share is based on the gain from continuing/discontinued operations
attributable to ordinary shareholders and the weighted average of total ordinary shares on issue during the
period. The calculation of diluted earnings per share has been based on the profit attributable to ordinary
shareholders and weighted-average number of ordinary shares outstanding after adjustment for the effects
of all dilutive potential ordinary shares.
At 30 September 2025, all convertible notes and warrants (30 September 2024: warrants, 31 March 2025:
warrants) were excluded from the diluted weighted average number of ordinary shares calculation because
their effect would have been anti-dilutive. The average market value of the Group’s shares for the purpose
of calculating the dilutive effect of convertible notes and warrants was based on quoted market prices for
the period during which the warrants were outstanding.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 18 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 25

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
NOTE 9: RELATED PARTY TRANSACTIONS
Related PartyRelationship
Brankin Family Interest TrustRelated to a shareholder and a director of the Group
Design Care Group LimitedRelated by common directors
Crafted Solutions LimitedRelated by common directors
(a)Transactions with related parties
30 September
2025
UNAUDITED
30 September
2024
UNAUDITED
$ '000$ '000
(105)(143)
(60)(176)
(36)(17)
Directors' fees
Consultancy fees paid to Design Care Group Limited
Consultancy fees paid to Crafted Solutions Limited
(b) Balances with related parties
During the year ended 31 March 2023 the Brankin Family Interest Trust paid taxes on behalf of the group
amounting to $0.175m. At reporting date $Nil was payable (30 September 2024: $0.175m, 31 March 2025:
$nil).
No balances with related parties were written off or forgiven in the period (30 September 2024: $nil, 31
March 2025: $nil)
NOTE 10: DISCONTINUED OPERATION
There were no discontinued operations during the current interim period. The Group disposed of its
discontinued operation in the prior financial year, and there have been no subsequent adjustments to
previously reported amounts, refer to note 29 of the Group’s audited consolidated financial statements for
the year ended 31 March 2025.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 19 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 26

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
NOTE 11: CAPITAL COMMITMENTS
The Group had a fixed price agreement for the development of ten premium care suites, which were
completed at a fixed price of $1.900m to be paid from ORA sale proceeds from the individual units.
As at 30 September 2025, the development of all premium care suites have been completed and sold.
Accordingly, the commitment balance as at 30 September 2025 is $nil (30 September 2024: $1.330m, 31
March 2025: $0.760m).
30 September
2025
UNAUDITED
($'000)
30 September
2024
UNAUDITED
($'000)
31 March
2025
AUDITED
($'000)
(a)Lease commitments
Non-cancelable operating leases contracted for but not
capitalised in the financial statements:
- not later than one year161621
- later than one year and not later than five years304538
466159
NOTE 12: LEASES
Accounting policy
The Group recognises a right-of-use asset and a corresponding lease liability at the commencement date of
a lease. The right-of-use asset is initially measured at cost and subsequently depreciated on a straight-line
basis over the lease term. The lease liability is initially measured at the present value of lease payments,
discounted using the Group’s incremental borrowing rate. Short-term leases (12 months or less) and leases
of low-value assets are expensed as incurred.
Key accounting estimates and judgements
Lease term: The Group determines the lease term as the non-cancellable period of the lease, together with
periods covered by an option to extend or terminate if it is reasonably certain to be exercised.
Discount rate: The Group uses its incremental borrowing rate of 7% at the lease commencement date to
discount lease payments.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 20 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 27

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
Note
30 September
2025
UNAUDITED
30 September
2024
UNAUDITED
31 March
2025
AUDITED
$ '000$ '000$ '000
NOTE 12: LEASES (CONTINUED)
During the period, the Group entered into a new lease agreement for office premises. The carrying
amounts are as follows:
153--
(21)--
132--
---
153--
(21)--
132--
49--
85--
134--
4--
20--
21--
(a) Right-of-use assets
Land and buildings under lease
Accumulated depreciation
Total carrying amount of right-of-use assets
Reconciliations
Reconciliation of the carrying amount of right-of-use
assets at the beginning and end of the financial period:
Land and buildings
Opening carrying amount
Additions
Depreciation
Closing carrying amount
(b) Lease liabilities
Current
Land and buildings
Non-current
Land and buildings
Total carrying amount of lease liabilities
(c) Lease expenses and cash flows
Interest expense on lease liabilities
Expense relating to lease payments made for leases
of low value assets (for which right-of-use assets
and lease liabilities have not been recognised)
Depreciation expense on right-of-use assets
Total cash outflow in relation to leases
52--
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 21 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 28

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
NOTE 12: LEASES (CONTINUED)
(d)Maturity analysis - contractual cash flows
30 September
2025
UNAUDITED
$
30 September
2024
UNAUDITED
$
31 March
2025
AUDITED
$
- Not later than 1 year56--
- Later than 1 year and not later than 5
years89--
145--
NOTE 13: CONTINGENT LIABILITIES
There are no contingent liabilities at 30 September 2025 (30 September 2024: $nil, 31 March 2025: $nil).
NOTE 14: EVENTS SUBSEQUENT TO REPORTING DATE
Prior to balance date, the Group entered into two unconditional sale agreements for its properties located
at 60 Aldwins Road and 74–76 Aldwins Road (recorded as non-current assets held for sale in the condensed
consolidated statement of financial position).
Settlement of both transactions is scheduled for late November 2025. The properties were sold at values
consistent with their carrying amounts in the Group’s books, and therefore no material gain or loss is
expected to arise on settlement. Proceeds from the sales will be used to repay the Group’s existing debt
facilities.
There have been no other matters or circumstances, which have arisen since
30 September 2025 that have
significantly affected or may significantly affect:
(a)the operations, in financial period subsequent to
30 September 2025, of the Group, or
(b)the results of those operations, or
(c)the state of affairs, in financial period subsequent to
30 September 2025, of the Group.
Compiled without undertaking an audit or review, refer to the Compilation Report on page 2
- 22 -
PROMISIA HEALTHCARE: INTERIM REPORT 2026 29

Directory
Registered office
Duncan Cotterill
Level 5, 50 Customhouse Quay
Wellington, 6011
Directors
Thomas Brankin
Craig Percy
Rhonda Sherriff
Jill Hatchwell
Tony Mortensen
Auditor
William Buck Audit (NZ) Limited
Bank
Bank of New Zealand
Solicitors
Duncan Cotterill
Wellington
PROMISIA HEALTHCARE: INTERIM REPORT 2026 30

www.promisia.co.nz

---

Results announcement



Results for announcement to the market
Name of issuer Promisia Healthcare Limited
Reporting Period 6 months to 30 September 2025
Previous Reporting Period 6 months to 30 September 2024
Currency NZD
Amount (000s) Percentage change
Revenue from continuing
operations
$19,183 5.2%
Total Revenue $19,183 -5 .0%
Net profit/(loss) from
continuing operations
$(49) -100.9%
Total net profit/(loss) $(49) -100.8%
Interim/Final Dividend
Amount per Quoted Equity
Security
No dividend is proposed
Imputed amount per Quoted
Equity Security
Not Applicable
Record Date Not Applicable
Dividend Payment Date Not Applicable
Current period Prior comparable period
Net tangible assets per
Quoted Equity Security
$0.79 $0.72
A brief explanation of any of
the figures above necessary
to enable the figures to be
understood
Please refer to attached documents (consolidated financial
Statements and results announcement).
Authority for this announcement
Name of person

authorised
to make this announcement
Rhonda Sherriff, Chair
Contact person for this
announcement
Francisco Rodriguez Ferrere, Chief Financial Officer
Contact phone number 021 245 1801
Contact email address Francisco.rf@promisia.co.nz
Date of release through MAP

12 November 2025

Unaudited financial statements accompany this announcement.